MLH1 and non-small cell lung carcinoma: These intriguing findings have been followed by a recent report that MSH2, but not MLH1, methylation is a marker of poor prognosis in a Taiwanese cohort of nonsmoking female NSCLC patients (Hsu et al, 2005).